Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of ornithine, proline and/or hydroxyproline.
Biomarker and diagnostic research for inborn disorder of ornithine, proline and hydroxyproline metabolism has been reported in the published literature.
No clinical trials have been registered for inborn disorder of ornithine, proline and hydroxyproline metabolism.
2 publications have been identified in PubMed for inborn disorder of ornithine, proline and hydroxyproline metabolism. Research spans Diagnostic / Biomarker (50%) and Epidemiology / Natural History (50%).
Spano J (2025). [PMID: 40603951](https://pubmed.ncbi.nlm.nih.gov/40603951/). *Scientific reports*. [Diagnostic / Biomarker]
Guo Y (2024). [PMID: 38851765](https://pubmed.ncbi.nlm.nih.gov/38851765/). *Orphanet journal of rare diseases*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 2:05 PM UTC